Lovenox (enoxaparin) is now approved to TREAT blood clots

February 1999

Lovenox (enoxaparin) is now approved to TREAT blood clots...it used to be approved only for PREVENTION.

It's the first low-molecular-weight heparin to be approved to treat acute deep vein thrombosis (DVT)...in both inpatient and outpatient settings.

Lovenox works as well as IV heparin to treat DVTs...but it's easier to administer and requires less lab monitoring.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote